221 related articles for article (PubMed ID: 34052033)
1. An overview of genetic predisposition to familial hematological malignancies.
Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
[TBL] [Abstract][Full Text] [Related]
2. ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Hamadou WS; Besbes S; Mani R; Bourdon V; Ben Youssef Y; Achour B; Regaieg H; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Bull Cancer; 2017 Feb; 104(2):123-127. PubMed ID: 27866680
[TBL] [Abstract][Full Text] [Related]
3. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.
Hamadou WS; Besbes S; Bourdon V; Youssef YB; Laatiri MA; Noguchi T; Khélif A; Sobol H; Soua Z
Fam Cancer; 2017 Jan; 16(1):153-157. PubMed ID: 27619989
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.
Hamadou WS; Mani R; Bouali N; Besbes S; Bourdon V; El Abed R; Ben Youssef Y; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
Bull Cancer; 2021 Sep; 108(9):798-805. PubMed ID: 34140154
[TBL] [Abstract][Full Text] [Related]
6. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.
Sud A; Chattopadhyay S; Thomsen H; Sundquist K; Sundquist J; Houlston RS; Hemminki K
Blood; 2019 Sep; 134(12):960-969. PubMed ID: 31395603
[TBL] [Abstract][Full Text] [Related]
8. [Genetics of hereditary hematological malignancies].
Takagi M
Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
10. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
11. Hematological Malignancies in Adults With a Family Predisposition.
Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
[TBL] [Abstract][Full Text] [Related]
12. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
[TBL] [Abstract][Full Text] [Related]
13. Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma.
Akhtar S; Rauf MS; Al-Kofide A; Elshenawy MA; Mushtaq AH; Maghfoor I
Hered Cancer Clin Pract; 2021 Feb; 19(1):17. PubMed ID: 33563316
[TBL] [Abstract][Full Text] [Related]
14. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
15. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
16. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
Zhao HY; Chen YX
Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
[TBL] [Abstract][Full Text] [Related]
17. Familial aggregation of Hodgkin lymphoma and related tumors.
Goldin LR; Pfeiffer RM; Gridley G; Gail MH; Li X; Mellemkjaer L; Olsen JH; Hemminki K; Linet MS
Cancer; 2004 May; 100(9):1902-8. PubMed ID: 15112271
[TBL] [Abstract][Full Text] [Related]
18. Familial hematological malignancies: ASXL1 gene investigation.
Hamadou WS; Abed RE; Besbes S; Bourdon V; Fabre A; Youssef YB; Laatiri MA; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Jemni SY; Noguchi T; Khélif A; Sobol H; Soua Z
Clin Transl Oncol; 2016 Apr; 18(4):385-90. PubMed ID: 26286068
[TBL] [Abstract][Full Text] [Related]
19. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.
Hamadou WS; Bourdon V; Gaildrat P; Besbes S; Fabre A; Youssef YB; Regaieg H; Laatiri MA; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Jemni SY; Noguchi T; Khélif A; Sobol H; Soua Z
Ann Hematol; 2016 Jun; 95(7):1043-50. PubMed ID: 27106701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
